vialroom

#cagrilintide 2026-04-30

Thursday52 messages13 participantstimes are UTC
Highlights from this day
  • olive_orders — has REDEFINE reported or are people quoting earlier work 19:21
  • rezept_rolf — changed my mind on this, i started thinking amylin was the interesting bit and now i think its the pairing, ill dig out the number 19:30
  • rezept_rolf — i said earlier this year that monotherapy did nothing for me, and at a higher dose it did something, n of 1 obviously 21:36
QH

held at 12 for 8 months on monotherapy before i touched it again

SB

added it to an existing tirzepatide dose rather than starting both, which made attribution possible

[edited]
SB

stopped for 14 months and the fullness went within a fortnight of the last dose

its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake

is there a reason people titrate this over more weeks than the others

😂1
WN

thats the phase 3 one

fridge-temps.csv
306 rows · not retained in the public archive
AA

does the fullness effect fade the way appetite suppression does

OO

the numbers everyone quotes come from the combination, so comparing them to monotherapy logs is unfair

is the slower titration because of nausea or something else

QH

REDEFINE is the phase 3 programme, most of what gets quoted casually in here is earlier work

QH

i titrated over twice as many weeks as i did on semaglutide and that was right for me

1
RR

changed my mind on this, i started thinking amylin was the interesting bit and now i think its the pairing, ill dig out the number

🔥14
TW

the reason nausea reads differently is timing, mine arrived on the second day rather than the first
dosing them on different days made no difference i could detect

LT

went slower because the first step gave me two rough days and i took that as information

🧪7

follow up combination GI was worse than either alone for me, which is not what i had read anywhere
the nausea felt different rather than less, more fullness and less of the queasy wave

amylin is about slowed gastric emptying and satiety signalling, thats the short version and im no pharmacologist

VB

Purity check: no report on file for lot SG-1177. Nothing logged either way.

TW

i keep the two on separate days so if something goes wrong i have a chance of knowing which

TT

for the archive monotherapy was underwhelming for me and i say that as someone who wanted it to work

TT

the fullness thing is the part people describe differently, food stops being interesting rather than repellent, from memory

[edited]

fullness rather than nausea

💀7⚠️2👍8
20:42quiet.hours pinned a message
MN

is the combination just the two dosed together or a single formulation

MN

if youre used to GLP-1 titration steps this feels absurdly cautious and i still do it that way

dosing them on different days made no difference i could detect

dropped the GLP-1 and stayed on this alone for 21 months, appetite held but weight barely moved

RR

30 in 3ml gives 10mg/ml which is what i use, purely because the units come out round

anyone stopped the GLP-1 and kept only this

i said earlier this year that monotherapy did nothing for me, and at a higher dose it did something, n of 1 obviously

👍2🧪10
MO

the slower titration in here is community habit as much as anything, the trials had their own schedule

TT

nobody should copy my schedule, im describing it because people asked what a slow ramp looks like

lost 103lb over 11 months on the combination and i genuinely cannot apportion it

separate days

👀3